Latest Ratios: P/E Ratio -6.1x · EV/EBITDA 56.3x · ROE -883.8%. (2008–2024 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2024 | FY 2022 | FY 2021 | FY 2020 | FY 2011 | FY 2010 | FY 2009 | FY 2008 |
|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $1.2B | $1.8B | $1.6B | $2.0B | $1.8B | — | — | — | — |
| Enterprise Value | $1.2B | $1.8B | $1.6B | $2.0B | $1.8B | — | — | — | — |
| P/E Ratio → | -6.09 | — | 29.16 | 74.19 | — | — | — | — | — |
| P/S Ratio | 21.64 | 31.67 | 27.98 | 20.16 | — | — | — | — | — |
| P/B Ratio | 27.08 | 39.55 | 5715.16 | 5180.18 | 3485.68 | — | — | — | — |
| P/FCF | — | — | — | — | — | — | — | — | — |
| P/OCF | — | — | — | — | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2024 | FY 2022 | FY 2021 | FY 2020 | FY 2011 | FY 2010 | FY 2009 | FY 2008 |
|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 31.05 | 27.97 | 20.15 | — | — | — | — | — |
| EV / EBITDA | 56.26 | 83.11 | 21.52 | 43.27 | 107.06 | — | — | — | — |
| EV / EBIT | 56.26 | — | 21.59 | 74.63 | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | — | — | — | — |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2024 | FY 2022 | FY 2021 | FY 2020 | FY 2011 | FY 2010 | FY 2009 | FY 2008 |
|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 100.0% | 100.0% | 100.0% | 100.0% | — | 99.7% | 99.5% | 96.1% | 99.7% |
| Operating Margin | 37.4% | 37.4% | 129.6% | 27.0% | — | 96.4% | 96.2% | 6.3% | 96.1% |
| Net Profit Margin | -356.1% | -356.1% | 95.4% | 27.0% | — | 1.7% | 5.6% | 6.2% | 4.5% |
| Metric | TTM | FY 2024 | FY 2022 | FY 2021 | FY 2020 | FY 2011 | FY 2010 | FY 2009 | FY 2008 |
|---|---|---|---|---|---|---|---|---|---|
| ROE | -883.8% | -883.8% | 16575.7% | 5842.7% | — | 7.4% | 9794.1% | 10293.9% | 3686.5% |
| ROA | -30.5% | -30.5% | 2658.9% | 1011.0% | — | 1.7% | 2486.6% | 2562.5% | 882.9% |
| ROIC | 312.9% | 312.9% | — | — | 0.0% | 407.9% | 147174.0% | 9884.2% | — |
| ROCE | 3.2% | 3.2% | 3612.9% | 1011.6% | 0.0% | 94.2% | 42710.5% | 2618.9% | — |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2024 | FY 2022 | FY 2021 | FY 2020 | FY 2011 | FY 2010 | FY 2009 | FY 2008 |
|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | — | — | — | — | — | — | — | — | — |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — |
| Net Debt / Equity | — | -0.77 | -2.23 | -2.31 | -2.76 | -0.24 | -0.13 | -0.16 | -0.26 |
| Net Debt / EBITDA | -1.65 | -1.65 | -0.01 | -0.02 | -0.08 | -0.12 | -0.00 | -0.00 | -0.00 |
| Debt / FCF | — | — | — | — | — | -1.04 | -0.00 | -0.00 | -0.00 |
| Interest Coverage | 1.09 | 1.09 | 3.90 | 1.38 | — | 46.30 | 32.91 | 1.81 | — |
Net cash position: cash ($35M) exceeds total debt ($0)
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2024 | FY 2022 | FY 2021 | FY 2020 | FY 2011 | FY 2010 | FY 2009 | FY 2008 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | — | — | — | — | — | — | — | — | — |
| Quick Ratio | — | — | — | — | — | — | — | — | — |
| Cash Ratio | — | — | — | — | — | — | — | — | — |
| Asset Turnover | — | 0.04 | 31.48 | 42.50 | — | 0.49 | 418.44 | 372.84 | 197.20 |
| Inventory Turnover | — | — | — | — | — | — | — | — | — |
| Days Sales Outstanding | — | — | — | — | — | — | — | — | — |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2024 | FY 2022 | FY 2021 | FY 2020 | FY 2011 | FY 2010 | FY 2009 | FY 2008 |
|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | 73.3% | 26.3% | 20.7% | 47.5% |
| Metric | TTM | FY 2024 | FY 2022 | FY 2021 | FY 2020 | FY 2011 | FY 2010 | FY 2009 | FY 2008 |
|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | 3.4% | 1.3% | — | — | — | — | — |
| FCF Yield | — | — | — | — | — | — | — | — | — |
| Buyback Yield | 0.3% | 0.2% | 0.1% | 0.0% | 0.0% | — | — | — | — |
| Total Shareholder Yield | 0.3% | 0.2% | 0.1% | 0.0% | 0.0% | — | — | — | — |
| Shares Outstanding | — | $100M | $87M | $87M | $85M | $72.90T | $71.37T | $70.06T | $59.34T |
Legacy reserve volatility
Based on reported figures, MHNC trades at a P/B of 0.38 as of 2025Q1, a significant discount to historical levels that suggests the market is pricing the entity as a liquidating run-off vehicle rather than a going-concern insurance franchise with future growth potential.
The compression in the P/B multiple from over 4.0x in 2021 to current levels indicates that investors have largely abandoned expectations for a return to underwriting profitability. This valuation appears to reflect the high probability that the remaining book value will be eroded by further reserve strengthening and administrative costs.
As reported in recent financial statements, the company's ROE has remained deeply negative, reaching -20.9% in 2025Q1, which underscores the inability of the current investment portfolio to generate sufficient yield to offset the persistent losses inherent in the legacy reinsurance book.
The lack of underwriting profit contribution to ROE suggests that the company is effectively a capital-depleting entity. Investors should monitor whether the investment yield can stabilize, though current trends indicate that non-operating costs and reserve adjustments continue to overwhelm any potential income from float.
According to quarterly data, the erosion of equity from $404.2M in 2021Q2 to $37.6M in 2025Q1 indicates that the company's underwriting leverage is no longer a meaningful metric, as the capital base has become too thin to support any significant new risk-taking activities.
The extreme reduction in equity suggests that the company is operating with minimal margin for error regarding its legacy liabilities. This vulnerability implies that any adverse development in claims could necessitate immediate capital intervention or further asset liquidation to maintain regulatory solvency.
As indicated by the provided data, the combined ratio is the most commonly misapplied metric for MHNC, as it fails to account for the volatility of reserve development and the lack of new premium volume in a closed-block run-off scenario.
Relying on the combined ratio obscures the reality that administrative expenses are now fixed costs against a shrinking premium base, rather than variable costs of active underwriting. Analysts should instead focus on the 'reserve-to-equity' ratio to better assess the potential for insolvency if legacy claims exceed current actuarial estimates.
Includes 30+ ratios · 8 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying MHNC stock.
Maiden Holdings North America, Ltd.'s current P/E ratio is -6.1x. The historical average is 51.7x.
Maiden Holdings North America, Ltd.'s current EV/EBITDA is 56.3x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 49.3x.
Maiden Holdings North America, Ltd.'s return on equity (ROE) is -883.8%. The historical average is 7.4%.
Based on historical data, Maiden Holdings North America, Ltd. is trading at a P/E of -6.1x. Compare with industry peers and growth rates for a complete picture.
Maiden Holdings North America, Ltd. has 100.0% gross margin and 37.4% operating margin. Operating margin above 20% indicates strong pricing power and cost efficiency.